Hyphens Pharma International Limited (SGX:1J5)
Singapore · Delayed Price · Currency is SGD 0.3350
-0.0050 (-1.47%)
At close: Jul 31, 2025
SGXC:1J5 Revenue
In the year 2024, Hyphens Pharma International had annual revenue of 195.42M SGD with 14.55% growth. Hyphens Pharma International had revenue of 51.88M in the quarter ending December 31, 2024, a decrease of -2.23%.
Revenue
195.42M
Revenue Growth
+14.55%
P/S Ratio
0.53
Revenue / Employee
420.26K
Employees
474
Market Cap
103.47M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 195.42M | 24.83M | 14.55% |
| Dec 31, 2023 | 170.60M | 8.28M | 5.10% |
| Dec 31, 2022 | 162.32M | 36.43M | 28.94% |
| Dec 31, 2021 | 125.88M | 4.91M | 4.06% |
| Dec 31, 2020 | 120.98M | 1.54M | 1.29% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| DBS Group Holdings | 21.83B |
| Oversea-Chinese Banking Corporation | 13.72B |
| Singapore Telecommunications | 14.15B |
| United Overseas Bank | 13.37B |
| Singapore Technologies Engineering | 11.28B |
| Jardine Matheson Holdings | 45.30B |
| Singapore Airlines | 19.54B |
| Wilmar International | 91.96B |